47 related articles for article (PubMed ID: 15640069)
1. [Association between mutation of phospholamban gene and dilated cardiomyopathy].
Zhao CX; Cui YH; Zhu ZH; Wang DW
Yi Chuan; 2004 Sep; 26(5):599-602. PubMed ID: 15640069
[TBL] [Abstract][Full Text] [Related]
2. Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy.
Minamisawa S; Sato Y; Tatsuguchi Y; Fujino T; Imamura S; Uetsuka Y; Nakazawa M; Matsuoka R
Biochem Biophys Res Commun; 2003 Apr; 304(1):1-4. PubMed ID: 12705874
[TBL] [Abstract][Full Text] [Related]
3. Mutational screening of phospholamban gene in hypertrophic and idiopathic dilated cardiomyopathy and functional study of the PLN -42 C>G mutation.
Medin M; Hermida-Prieto M; Monserrat L; Laredo R; Rodriguez-Rey JC; Fernandez X; Castro-Beiras A
Eur J Heart Fail; 2007 Jan; 9(1):37-43. PubMed ID: 16829191
[TBL] [Abstract][Full Text] [Related]
4. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in a Northern Greek population.
Kalemi T; Efthimiadis G; Zioutas D; Lambropoulos A; Mitakidou A; Giannakoulas G; Vassilikos V; Karvounis H; Kotsis A; Parharidis G; Louridas G
Biochem Genet; 2005 Dec; 43(11-12):637-42. PubMed ID: 16382369
[TBL] [Abstract][Full Text] [Related]
5. Messenger RNA expression and immunological quantification of phospholamban and SR-Ca(2+)-ATPase in failing and nonfailing human hearts.
Linck B; Bokník P; Eschenhagen T; Müller FU; Neumann J; Nose M; Jones LR; Schmitz W; Scholz H
Cardiovasc Res; 1996 Apr; 31(4):625-32. PubMed ID: 8689655
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the structure and function of phospholamban and the arginine-14 deficient mutant associated with dilated cardiomyopathy.
Hughes E; Middleton DA
PLoS One; 2014; 9(9):e106746. PubMed ID: 25225809
[TBL] [Abstract][Full Text] [Related]
7. [Association between phospholamban gene mutation and dilated cardiomyopathy in the Chengdu area].
Chen XY; Rao L; Zhou B; Zhang L; Chen H; Wang YP; Wang B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):683-5. PubMed ID: 16235537
[TBL] [Abstract][Full Text] [Related]
8. A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.
Haghighi K; Kolokathis F; Gramolini AO; Waggoner JR; Pater L; Lynch RA; Fan GC; Tsiapras D; Parekh RR; Dorn GW; MacLennan DH; Kremastinos DT; Kranias EG
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1388-93. PubMed ID: 16432188
[TBL] [Abstract][Full Text] [Related]
9. Phospholamban gene mutations are not associated with hypertrophic cardiomyopathy in patients from southern Poland.
Petkow-Dimitrow P; Kieć-Wilk B; Kwaśniak M; Mikołajczyk M; Dembińska-Kieć A
Kardiol Pol; 2011; 69(2):134-7. PubMed ID: 21332051
[TBL] [Abstract][Full Text] [Related]
10. Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts.
Movsesian MA; Colyer J; Wang JH; Krall J
J Clin Invest; 1990 May; 85(5):1698-702. PubMed ID: 2139670
[TBL] [Abstract][Full Text] [Related]
11. Deception in simplicity: hereditary phospholamban mutations in dilated cardiomyopathy.
Young HS; Ceholski DK; Trieber CA
Biochem Cell Biol; 2015 Feb; 93(1):1-7. PubMed ID: 25563649
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
[TBL] [Abstract][Full Text] [Related]
13. Phospholamban: a crucial regulator of cardiac contractility.
MacLennan DH; Kranias EG
Nat Rev Mol Cell Biol; 2003 Jul; 4(7):566-77. PubMed ID: 12838339
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone enhances Ca2+ pumping activity of the cardiac sarcoplasmic reticulum by increasing Ca2+ ATPase and decreasing phospholamban expression.
Kimura Y; Otsu K; Nishida K; Kuzuya T; Tada M
J Mol Cell Cardiol; 1994 Sep; 26(9):1145-54. PubMed ID: 7815458
[TBL] [Abstract][Full Text] [Related]
15. The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.
Paterlini MG; Thomas DD
Biophys J; 2005 May; 88(5):3243-51. PubMed ID: 15764655
[TBL] [Abstract][Full Text] [Related]
16. Solid-state NMR measurements of the kinetics of the interaction between phospholamban and Ca2+-ATPase in lipid bilayers.
Hughes E; Middleton DA
Mol Membr Biol; 2005; 22(4):353-61. PubMed ID: 16154906
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
[TBL] [Abstract][Full Text] [Related]
18. A study in Polish patients with cardiomyopathy emphasizes pathogenicity of phospholamban (PLN) mutations at amino acid position 9 and low penetrance of heterozygous null PLN mutations.
Truszkowska GT; Bilińska ZT; Kosińska J; Śleszycka J; Rydzanicz M; Sobieszczańska-Małek M; Franaszczyk M; Bilińska M; Stawiński P; Michalak E; Małek ŁA; Chmielewski P; Foss-Nieradko B; Machnicki MM; Stokłosa T; Ponińska J; Szumowski Ł; Grzybowski J; Piwoński J; Drygas W; Zieliński T; Płoski R
BMC Med Genet; 2015 Apr; 16():21. PubMed ID: 25928149
[TBL] [Abstract][Full Text] [Related]
19. Evidence for calcineurin-mediated regulation of SERCA 2a activity in human myocardium.
Münch G; Bölck B; Karczewski P; Schwinger RH
J Mol Cell Cardiol; 2002 Mar; 34(3):321-34. PubMed ID: 11945024
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of phospholamban by cAMP-dependent protein kinase enhances interactions between Ca-ATPase polypeptide chains in cardiac sarcoplasmic reticulum membranes.
Negash S; Chen LT; Bigelow DJ; Squier TC
Biochemistry; 1996 Sep; 35(35):11247-59. PubMed ID: 8784178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
